About Cutaneous Lymphoma

Kyowa Hakko Kirin Announces Results from US Phase 1/2 Clinical Trial of KW-0761 (Anti-CCR4 Humanized Monoclonal Antibody) in Patients with Cutaneous T-cell Lymphoma

Wed, 12/08/2010

 

Click here to read more on Kyowa Hakko Kirin Announcement from US Phase 1/2 Clinical Trial results of Anti-CCR4 Humanized Monoclonal Antibody.

English French German Italian Portuguese Russian Spanish

This is an automatic translation service and therefore the
Cutaneous Lymphoma Foundation is not responsible
for any potential translation inaccuracies.